Novel diorganotin(IV) complexes were synthesized from 1,2,4-triazole Schiff base ligands which
were synthesized by reaction between the 4-amino-5-phenyl-1,2,4-triazole-3-thiol and salicyaldehyde
derivatives. The bonding and geometry of the diorganotin(IV) complexes were evaluated by using
different spectroscopic techniques such as FT-IR, mass, 1H, 13C & 119Sn NMR. The different
spectroscopic techniques revealed the tridentate (ONS) mode of chelation of Schiff base ligands and
pentacoordinated environment around the central tin metal which was satisfied with azomethine
nitrogen, phenolic oxygen, thiolic sulfur and metal-carbon bond of alkyl/aryl group. The Schiff base
ligands and their organotin(IV) complexes were tested for their in vitro antimicrobial and antioxidant
activities to examine the biological outline of complexes in comparison to standard drugs. The results
of activities data revealed that diorganotin(IV) complexes are more active than Schiff base ligands and
some diorganotin(IV) complexes are even more active than the standard drugs. In all the synthesized
complexes, compound 9 (Bu2SnL2) and 10 (Ph2SnL2) were most potent and can be used in future
clinical trials.